Products for Research Use Only

Ephrin-B2, soluble

CAT: 0209-S01-068Size: 50 µgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0209-S01-068Size:50 µg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
The large families of Eph receptor tyrosine kinases and their Ephrin ligands transduce signals in a cell-cell contact-dependent fashion. They thereby coordinate the growth, differentiation, and patterning of almost every organ and tissue. Eph/Ephrin interactions can trigger a wide array of cellular responses, including cell adhesion, boundary formation, and repulsion. The exact mechanisms leading to this diversity of responses are unclear but appear to involve differential signaling, proteolytic cleavage of Ephrins, and endocytosis of the ligand-receptor complex. In the developing cardiovascular system, Eph and Ephrin molecules control the angiogenic remodeling of blood vessels and lymphatic vessels and play essential roles in endothelial cells as well as in supporting pericytes and vascular smooth muscle cells. Recent evidence suggests that Ephs and Ephrins may also be involved in pathological angiogenesis, in particular, the neovascularization of tumors. Consequently, the expression, interactions, or signaling of Eph/Ephrin molecules might be targets for future therapeutic approaches. Ephrins are naturally divided into two structural groups. All ligands share a conserved extracellular sequence, which most likely corresponds to the receptor-binding domain. This conserved sequence consists of approximately 125 amino acids and includes four invariant cysteines. The B-class ligands are transmembrane proteins, which can be tyrosine phosphorylated upon receptor ligation. Class B ephrins show 33% amino acid sequence identity in their extracellular segments and 44% amino acid sequence identity in their cytoplasmic regions.
Synonyms
EPH-related receptor tyrosine kinase ligand 5; HTK ligand
NCBI Gene ID
1948
UniProt
P52799
Accession Number
NP_004084.1
Accession Number mRNA
NM_004093.3
Reactivity
Human
Cross Reactivity
Human
Label
His-Tag
Sequence
MIVLEPIYWNSSNSKFLPGQGLVLYPQIGDKLDIICPKVDSKTVGQYEYYKVYMVDKDQADRCTIKKENTPLLNCAKPDQDIKFTIKFQEFSPNLWGLEFQKNKDYYIISTSNGSLEGLDNQEGGVCQTRAMKILMKVGQDASSAGSTRNKDPTRRPELEAGTNGRSSTTSPFVKPNPGSSTDGNSAGHSGNNILGSEVALFALEHHHHHH
Purity
> 95% by SDS-PAGE
Length
211
Form
Lyophilized
Molecular Weight
23.4 kDa
Host or Source
E. coli
N Terminal Sequence
MIVLE

Alternative Products

CatalogName
MBS692282-01Human Ephrin-B2, soluble
YP-W24283-01Mouse Soluble Ephrin-B2 (SEFNB2) ELISA Kit
207598EPHB4 (HTK, MYK1, TYRO11, EPH Receptor B4, Ephrin Receptor EphB4, Hepatoma Transmembrane Kinase, Soluble EPHB4 Variant 1, Soluble EPHB4 variant 2, Soluble EPHB4 Variant 3)
207598-HRPEPHB4 (HTK, MYK1, TYRO11, EPH Receptor B4, Ephrin Receptor EphB4, Hepatoma Transmembrane Kinase, Soluble EPHB4 Variant 1, Soluble EPHB4 variant 2, Soluble EPHB4 Variant 3) (HRP)
MBS6140084-01EPHB4 (HTK, MYK1, TYRO11, EPH Receptor B4, Ephrin Receptor EphB4, Hepatoma Transmembrane Kinase, Soluble EPHB4 Variant 1, Soluble EPHB4 variant 2, Soluble EPHB4 Variant 3) APC
207598-FITCEPHB4 (HTK, MYK1, TYRO11, EPH Receptor B4, Ephrin Receptor EphB4, Hepatoma Transmembrane Kinase, Soluble EPHB4 Variant 1, Soluble EPHB4 variant 2, Soluble EPHB4 Variant 3) (FITC)
207598-BiotinEPHB4 (HTK, MYK1, TYRO11, EPH Receptor B4, Ephrin Receptor EphB4, Hepatoma Transmembrane Kinase, Soluble EPHB4 Variant 1, Soluble EPHB4 variant 2, Soluble EPHB4 Variant 3) (Biotin)
207598-APCEPHB4 (HTK, MYK1, TYRO11, EPH Receptor B4, Ephrin Receptor EphB4, Hepatoma Transmembrane Kinase, Soluble EPHB4 Variant 1, Soluble EPHB4 variant 2, Soluble EPHB4 Variant 3) (APC)
MBS6161296-01EPHB4 (HTK, MYK1, TYRO11, EPH Receptor B4, Ephrin Receptor EphB4, Hepatoma Transmembrane Kinase, Soluble EPHB4 Variant 1, Soluble EPHB4 variant 2, Soluble EPHB4 Variant 3) (PE)
MBS6134781-01EPHB4 (HTK, MYK1, TYRO11, EPH Receptor B4, Ephrin Receptor EphB4, Hepatoma Transmembrane Kinase, Soluble EPHB4 Variant 1, Soluble EPHB4 variant 2, Soluble EPHB4 Variant 3) (AP)